These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 9666226)

  • 1. Plasma lipoproteins as cardiovascular risk factors in diabetes.
    Manzato E
    Aging (Milano); 1998 Apr; 10(2):169-70. PubMed ID: 9666226
    [No Abstract]   [Full Text] [Related]  

  • 2. [Diabetes and dyslipidemia].
    Fatati G
    Recenti Prog Med; 1999 Jan; 90(1):21-4. PubMed ID: 10193161
    [No Abstract]   [Full Text] [Related]  

  • 3. Attenuating cardiovascular risk factors in patients with type 2 diabetes.
    Garber AJ
    Am Fam Physician; 2000 Dec; 62(12):2633-42, 2645-6. PubMed ID: 11142470
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Measure for measure--sugar or fats? Reconciling cardiovascular and diabetes risk with niacin therapy.
    Rosenson RS
    Nat Clin Pract Endocrinol Metab; 2007 Feb; 3(2):72-3. PubMed ID: 17237831
    [No Abstract]   [Full Text] [Related]  

  • 5. Diabetic dyslipidemia.
    Chahil TJ; Ginsberg HN
    Endocrinol Metab Clin North Am; 2006 Sep; 35(3):491-510, vii-viii. PubMed ID: 16959582
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Disorders of lipid metabolism in 3 patients with diabetes mellitus type 2].
    Wolffenbuttel BH; Huijberts MS
    Ned Tijdschr Geneeskd; 2001 Apr; 145(16):761-5. PubMed ID: 11346911
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Screening for type 2 diabetes mellitus in adults.
    Fink K; Clark B
    Am Fam Physician; 2004 Feb; 69(3):605-6. PubMed ID: 14971844
    [No Abstract]   [Full Text] [Related]  

  • 8. [Dyslipidemia, diabetes and cardiovascular disease].
    Hansen CN; Jensen TJ; Borch-Johnsen K
    Ugeskr Laeger; 2000 Aug; 162(33):4367-70. PubMed ID: 10962957
    [No Abstract]   [Full Text] [Related]  

  • 9. [Dyslipidemia of diabetes and insulin resistance].
    Halimi S
    Nephrologie; 2000; 21(7):345-6. PubMed ID: 11200607
    [No Abstract]   [Full Text] [Related]  

  • 10. [Dyslipidemia in diabetes mellitus].
    Niemeijer-Kanters SD; Banga JD; Erkelens DW
    Ned Tijdschr Geneeskd; 2001 Apr; 145(16):769-74. PubMed ID: 11346913
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyperlipidemia and cardiovascular risk factors in patients with type 2 diabetes.
    Goldberg RB
    Am J Manag Care; 2000 Aug; 6(13 Suppl):S682-91; discussion S692-6. PubMed ID: 11183421
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inflammatory variables may mediate the link between low plasma vitamin B6 concentrations and cardiovascular disease in type 2 diabetes.
    Cigolini M; Iagulli MP; Miconi V; Lorenzi T; Lombardi S; Targher G
    Nutr Metab Cardiovasc Dis; 2006 Oct; 16(7):e9-e10. PubMed ID: 16860546
    [No Abstract]   [Full Text] [Related]  

  • 13. Fenofibrate and rosiglitazone improve quality of lipoproteins in patients with type 2 diabetes mellitus.
    Vrablík M; Dobiásová M; Stulc T; Kasalová Z; Dolezalová R; Prázný M; Fait T; Ceska R
    Neuro Endocrinol Lett; 2008 Feb; 29(1):146-50. PubMed ID: 18283261
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-insulin-dependent diabetes mellitus and atherosclerosis: a lipoprotein perspective.
    Hamsten A; Steiner G
    J Intern Med Suppl; 1994; 736():1-3. PubMed ID: 7986301
    [No Abstract]   [Full Text] [Related]  

  • 15. [Multifactorial approach of the cardiovascular risks in case of diabetes].
    Ducobu J
    Rev Med Brux; 2005 Sep; 26(4):S255-63. PubMed ID: 16240871
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cardiovascular risk factors after menopause].
    Morra G; Prelato L; Belforte P; Corea R
    Minerva Ginecol; 1983 Mar; 35(3):101-8. PubMed ID: 6856179
    [No Abstract]   [Full Text] [Related]  

  • 17. Lipids in type 2 diabetes.
    Laakso M
    Semin Vasc Med; 2002 Feb; 2(1):59-66. PubMed ID: 16222596
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Management of diabetes in cardiac diseases].
    Işik S; Delibaşi T; Berker D; Aydin Y; Güler S
    Anadolu Kardiyol Derg; 2009 Jun; 9(3):238-47. PubMed ID: 19520659
    [TBL] [Abstract][Full Text] [Related]  

  • 19. B-type natriuretic peptide as an alternative way of assessing total cardiovascular risk in patients with diabetes mellitus.
    Dawson A; Jeyaseelan S; Morris AD; Struthers AD
    Am J Cardiol; 2005 Oct; 96(7):933-4. PubMed ID: 16188519
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monitoring of cardiovascular risk factors in the diabetic clinics of an Italian region: the MOFRAD study.
    Parillo M; Genovese S; Rivellese AA
    Diabetes Nutr Metab; 2001 Aug; 14(4):212-6. PubMed ID: 11716291
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.